Disease on EC 1.14.19.28 - sn-1 stearoyl-lipid 9-desaturase
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Carcinogenesis
DESC1, a novel tumor suppressor, sensitizes cells to apoptosis by down-regulating the EGFR/AKT pathway in esophageal squamous cell carcinoma.
Carcinoma
Crystal structure of the catalytic domain of DESC1, a new member of the type II transmembrane serine proteinase family.
Carcinoma
DESC1, a novel tumor suppressor, sensitizes cells to apoptosis by down-regulating the EGFR/AKT pathway in esophageal squamous cell carcinoma.
Carcinoma
Differential expression of a novel serine protease homologue in squamous cell carcinoma of the head and neck.
Carcinoma
Expression of the serine protease DESC1 correlates directly with normal keratinocyte differentiation and inversely with head and neck squamous cell carcinoma progression.
Carcinoma
Human DESC1 serine protease confers tumorigenic properties to MDCK cells and it is upregulated in tumours of different origin.
Carcinoma
LncRNA LOXL1-AS1 promotes esophageal squamous cell carcinoma progression by targeting DESC1.
Carcinoma
LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
Carcinoma, Squamous Cell
Crystal structure of the catalytic domain of DESC1, a new member of the type II transmembrane serine proteinase family.
Carcinoma, Squamous Cell
Differential expression of a novel serine protease homologue in squamous cell carcinoma of the head and neck.
Carcinoma, Squamous Cell
Expression of the serine protease DESC1 correlates directly with normal keratinocyte differentiation and inversely with head and neck squamous cell carcinoma progression.
Carcinoma, Squamous Cell
Human DESC1 serine protease confers tumorigenic properties to MDCK cells and it is upregulated in tumours of different origin.
Coronavirus Infections
DESC1 and MSPL activate influenza A viruses and emerging coronaviruses for host cell entry.
Esophageal Squamous Cell Carcinoma
DESC1, a novel tumor suppressor, sensitizes cells to apoptosis by down-regulating the EGFR/AKT pathway in esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
LncRNA LOXL1-AS1 promotes esophageal squamous cell carcinoma progression by targeting DESC1.
Esophageal Squamous Cell Carcinoma
LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
Influenza, Human
DESC1 and MSPL activate influenza A viruses and emerging coronaviruses for host cell entry.
Neoplasms
Crystal structure of the catalytic domain of DESC1, a new member of the type II transmembrane serine proteinase family.
Neoplasms
DESC1, a novel tumor suppressor, sensitizes cells to apoptosis by down-regulating the EGFR/AKT pathway in esophageal squamous cell carcinoma.
Neoplasms
Human DESC1 serine protease confers tumorigenic properties to MDCK cells and it is upregulated in tumours of different origin.
Severe Acute Respiratory Syndrome
DESC1 and MSPL activate influenza A viruses and emerging coronaviruses for host cell entry.
Squamous Cell Carcinoma of Head and Neck
Expression of the serine protease DESC1 correlates directly with normal keratinocyte differentiation and inversely with head and neck squamous cell carcinoma progression.
html completed